Table 2.
Baseline | Compared value | RR | 95%CI | P |
---|---|---|---|---|
Severity <200 PMN | 200–500 PMN | 0.58 | 0.41‐0.82 | .001 |
>500 PMN | 0.47 | 0.32‐0.71 | .0003 | |
Age group <20 years | 20–40 years | 1.43 | 0.97‐2.12 | .06 |
40–60 years | 2.01 | 1.31‐3.08 | .001 | |
>60 years | 5.08 | 3.22‐8.02 | <.00001 | |
Dose <2.5 mg/kg | 2.5‐3.5 | 1.33 | 0.87‐2.03 | .17 |
>3.5 | 1.04 | 0.65‐1.67 | .85 | |
Int Dx‐ ATG <30 days | 30–120 days | 1.57 | 1.10‐2.25 | .01 |
>120 days | 1.66 | 1.08‐2.55 | .02 | |
EBMT/ASIA EBMT | ASIA | 0.98 | 0.64‐1.50 | .9 |
Year of ATG 2001–2008 | >2008 | 0.77 | 0.56‐1.07 | .12 |
Gender Male | female | 0.76 | 0.57‐1.03 | .07 |
Abreviations: As in Table 1; PMN = neutrophils; Dose: indicates mg/kg/day and should be multiplied ×5, for the total dose in mg/kg.